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ABSTRACT
The synthesis of phospholipids and glycolipids during the cell mitotic cycle of an
established hamster line, NIL, has been studied . Cells were synchronized with
excess thymidine and mitotically harvested by shaking . Cells were radioactively
labeled for 4 h with palmitate, glucosamine, or galactose . Lipids were analyzed by
thin-layer chromatography . As cells progressed through the mitotic cycle, incorpo-
ration into phospholipids increased but the fraction represented by each remained
constant. Similarly, ceramide monohexoside, dihexoside, and hematoside were
labeled equally in all phases . Ceramide trihexoside and tetrahexoside were labeled
only during G, and S .
Ceramide pentahexoside (the Forssman antigen) shows density-dependent syn-
thesis, accumulation, and reactivity. Ceramide pentahexoside was labeled during
all phases of the mitotic cycle but the rate of incorporation decreased in S and G2.
The total amount of lipid assayed immunologically in cell extracts gradually
increased.
Exposure of the Forssman antigen in untreated or trypsin-treated cells was
studied using binding of chemically labeled anti Forssman antiserum. The amount
of antigen detected in trypsinized cells increased during G, and early S but then
remained constant . Mitotic cells exposed all detectable antigen . As cells progressed
through the mitotic cycle, a large fraction of the Forssman antigen became cryptic .
INTRODUCTION
A number of laboratories have studied the metabo-
lism of glycolipids in normal and transformed cells
(1-18). In general, it has been proposed that
transformed cells are blocked in the synthesis of
various complex glycolipids. However, in some cell
lines, the glycolipid pattern of transformed cells
resembles the pattern observed in rapidly growing
normal cells (2, 12). We were interested in comple-
menting the study of the metabolism of glycolipids
during the growth cycle (15) with a study of their
synthesis during the mitotic cycle .
Previous studies on the synthesis of membranes
during the mitotic cycle are conflicting . Some of
the conflicts may be due to a loss of synchrony, to
perturbations caused by the method of synchroni-
zation, to variations among cells in the composi-
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different membranes within a cell . Most experi-
ments have employed incorporation of radioac-
tively labeled precursors as a probe for synthesis
without any attempt to measure possible turnover,
conversion of label, pool sizes, or transport rates .
This is especially important in light of recent
experiments showing that the transport of thymi-
dine, uridine, and an amino acid analog varies
during the mitotic cycle (19). Further, although
membrane fractions were isolated in some studies
(20-22), no attempts have been made to purify
individual components . The observations can be
summarized as follows : (a) synthesis of membrane
components throughout the mitotic cycle parallel-
ing protein increases (21, 23, 24) ; (b) preferential
synthesis of all components during one phase (20,
22, 25); or (c) preferential synthesis of different
components during different phases of the mitotic
cycle (26-29) .
In contrast to these results, studies of the
cellular surface architecture during the mitotic
cycle have been consistent . Antigenic "sites" which
are unreactive during S become reactive during
mitosis (30--37) . These sites include the fluorescent
wheat germ agglutination binding site (31, 32), H-2
antigens (33, 36), Moloney virus-induced surface
antigens (33, 35), H blood group antigen (30, 37),
and surface antigens of a murine lymphoma (34) .
Often, increased reactivity is also observed in G 2
(36) and G, (33-37), but it is not clear whether this
reflects a unique state of surface architecture
present in G, or G2, or an approach to or recovery
from the mitotic state of the surface. It might also
result from a contaminating population of mitotic
cells . At mitosis, cells (a) are more susceptible to
virus-induced fusion (38), (b) release half the
surface-bound heparan sulfate (39), (c) have in-
creased electrophoretic mobility (40), and (d)
permanently expose newly synthesized glyco-
proteins (41 -43).
Recently, the structure of the Forssman antigen
was clarified (44) . It is one of the neutral glycolip-
ids present in the NIL hamster line, and the
reactivity (45), synthesis (4, 6, 12-16), and quantity
(6) of this antigen have been found to vary with cell
density. In many ways the Forssman antigen is
similar to the lectin agglutination sites which have
been extensively studied (32, 46, 47). Like lectin
agglutination sites, this antigen is more readily
detected in virally transformed cells (48-52) or
upon trypsin treatment of normal cells (51, 52).
Since the wheat germ lectin binding site is one of
the determinants exposed during the mitotic cycle
(31), we were interested in the behavior of the
Forssman antigen during the mitotic cycle .
MATERIALS AND METHODS
Synchronization
Clone 20 of the NIL hamster line was isolated and
characterized in this laboratory (13), and was used 6-10
passages after clonal isolation . Cells were grown in
Dulbecco's modification of Eagle's minimal essential
medium containing four times the concentration of
amino acids and vitamins in Dulbecco's, plus 50 µg/ml
streptomycin and 75 U/ml penicillin (MEM-4x),
(Grand Island Biological Co., Grand Island, N. Y .), as
described in Sakiyama et al . (13).
Cells were synchronized with a double thymidine
block (53), or with a double thymidine block plus a
mitotic collection (54) with Colcemid (CIBA Phar-
maceutical Co., Summit, N . J .) as follows. In the double
thymidine block procedure, cells were treated with 3 mM
thymidine (A grade, Calbiochem, San Diego, Calif .), for
8-10 h, washed twice with serum-free medium, incubated
with 0.5 mM 2'-deoxycytidine-HCI (grade 11, Sigma
Chemical Co. . St. Louis, Mo.), and no thymidine for 6-8
h, washed, blocked with thymidine for 8 h, washed, and
released with deoxycytidine. This procedure was em-
ployed for the experiments mentioned in Figs. I, 2 A, 3
B, 4 B, 5 (right third), and Tables I I and III (right third) .
In order to obtain synchronized cells during G,, cells
released from a double thymidine block were mitotically
harvested in Colcemid as follows . At 5 h after release
from thymidine, cells were washed and incubated for 2 h
in 15 ml of Joklik-modified minimal essential medium
for spinner culture (Grand Island Biological Co.), plus
four times the concentration of amino acids and vitamins
in Dulbecco's, 10% fetal calf serum (Microbiological
Associates, Inc., Bethesda, Md.), and 0.3 mg/ml Colce-
mid . Recovery from Colcemid arrest was reversible as
judged by normal plating efficiency upon removal .
Mitotic cells were harvested by shaking glass Blake
bottles (200 cm2). The bottle was held in a horizontal
position and rocked manually from side to side 40 times .
Selective detachment of refractile cells was monitored by
phase-contrast light microscopy . Medium was harvested
by decanting. Cells were centrifuged at 150 g for 5 min.
Between 2 and 7 x 10' cells were obtained from 15
bottles (20-60% yield). The yield depended upon the
density of cells in the Blake bottle . Cultures of sparse
cells (<1 .5 x 10' cells/cm2) gave a higher percentage
yield than dense cultures (>1 .5 x 10' cells/cm2). The
mitotic index was assayed by swelling in hypotonic buffer
and scoring the presence or absence of nuclear envelope
(55). Cells were >95% viable as judged by trypan blue
exclusion. This procedure was employed for the experi-
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677ments mentioned in Figs. 2 B, 3 A, 4 A, 5 (left
two-thirds), 6-8, and Tables 11 and III (left two-thirds),
IV, V, and VII .
Radiolabeling
Radioactively labeled compounds were obtained from
New England Nuclear, Boston, Mass . To measure DNA
synthesis, cells on cover slips were pulsed for I h with
[meth yl-°H]thymidine (5I Ci/mmol, 10 µCi/ml for thy-
midine-released cells; 6.7 Ci/mmol, I uCi/ml for mitoti-
cally collected cells), washed by dipping in solution A
(phosphate-buffered saline without Ca+' or Mg" [60]),
and precipitated by immersion into 100% methanol .
Cover slips were broken and inserted into counting fluid
and counted in a Beckman liquid scintillation counter,
LS-230 (Beckman Instruments, Inc., Fullerton, Calif .).
[l-"C]Palmitic acid (59 mCi/mmol) medium was
prepared according to Robbins and Macpherson (12).
Cells were labeled in MEM-4x for 4 h with I µCi/ml
[1-'"C]palmitate, 2.5 µCi/ml [I-'"C]glucosamine-HCI
(58 mCi/mmol), or 2.5 µCi/ml [U-"C]galactose (63 .5
mCi/mmol), washed five times with solution A, and
scraped into solution A or 100% methanol .
Extraction of Lipids and Analysis
Cells harvested in solution A were centrifuged and
drained . Cells scraped in methanol were dried under
nitrogen. No differences in lipid recovery were observed
between methods but recovery of protein was better when
solution A was used to harvest cells. Dry pellets were
extracted three times with I ml chloroform-methanol
(2: I). Aliquots were counted and the rest of the solution
was dried under nitrogen .
Lipid extracts were applied to activated (I h, 110°C),
precoated thin-layer chromatographic plates (Silplate
F-22, Brinkmann Instruments, Inc., Westbury, N . Y ., or
Merck silica gel F-254, Merck Chemical U.S.A., Rah-
way, N. J.). Plates were run in ascending chromatog-
raphy according to Gray (56) as modified by Robbins
and Macpherson (12). The first solvent system was
chloroform-methanol-water (65 :25:4). The second sol-
vent system was developed perpendicular to the first
and consisted of tetrahydrofuran-dimethoxymethane-
methanol-water (60 :36:30:6). Plates were dried over-
night over desiccant between first and second directions .
X-ray films (RP-R2, Eastman Kodak Co., Rochester,
N. Y.) were exposed to the plates and radioactive spots
were scraped and counted without prior elution . The
silica gel did not result in quenching of "C counts . Pal-
mitate data are expressed as counts in a lipid divided by
counts in phospholipids plus glycolipids x 100. Protein
was determined according to Lowry et al . (57) on total
cells (Fig. 3, 6 A) or on lipid-extracted cells (Fig . 6 B and
Tables IV, V) using bovine serum albumin as a stan-
dard .
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Inhibition of Hemolysis by Cell Extracts
Lipid cell extracts were dried under nitrogen . 0.1 ml of
100% methanol containing I mg/ml azolecithin (purified
soya phosphatides, Associated Concentrates, Woodside,
N. Y.) was added and mixed vigorously . 0.9 ml of fresh
diluent buffer (0 .14 M NaCl, 0.01 M tris[hydroxy-
methyl]aminomethane, 5 mM MgSO,, 1 .5 mM CaCI2,
pH 7.4, I mg/ml gelatin) was added and gently mixed by
pipetting . Twofold serial dilutions were made. To the
0.5-m1 test sample, 0 .1 ml commercial antisheep hemoly-
sin (Grand Island Biological Co .), diluted 1 :5,000 in
fresh diluent buffer, was added and the sample was
incubated 90 min at 37 ° C . Then 0.5 ml washed 1% sheep
red blood cells (Connecticut Valley Biological Supply
Co ., Southampton, Mass. or Scott Laboratories, Inc.,
Fiskeville, R. 1.), plus guinea pig complement (1 : 140
dilution, Grand Island Biological Co .), was added and
incubated 75 min at 37 ° C. The test tubes were chilled in
ice and centrifuged. Supernates were read with a Zeiss
PM QII 15,000 spectrophotometer (Carl Zeiss, Inc.,
New York), at 550 nm to measure hemoglobin release .
Standards containing 0-0.5 ml hemolysin, diluted
1 : 16,000, and crude antigen extracts were included each
time as standards. Sheep red blood cells were between I
and 4 wk old for all experiments . No lysis occurred
without antibody, and anticomplement activity was not
observed .
Binding of Radioactive Antibody to
Whole Cells
Rabbit antiserum prepared against purified Forssman
glycolipid was kindly supplied by Dr . S. Hakomori (45).
An equal volume of saturated (NH,) 2SO, (wt/vol) was
added to the antiserum . The washed precipitate was
dialyzed and labeled with ["C ]formaldehyde (New Eng-
land Nuclear, 59 mCi/mmol) according to Rice and
Means (58). Binding studies were done with intact mono-
layers preincubated with 0.3 mg/ml bovine serum al-
bumin (Armour Pharmaceutical Co ., Chicago, 111.) and
0.3 mg/ml rabbit gamma globulin (kindly supplied by
Dr. L. Steiner, Massachusetts Institute of Technology,
Cambridge, Mass.) at 37 °C for 15 min. Radioactive
antiserum (12.5 µg, 1,000 cpm/µg) was added and
cells were incubated on ice for 10 min . Binding was com-
plete by 10 min (61). Plates were washed with solution A,
scraped, and counted. Binding studies with trypsinized
cells were carrried out similarly except for the following
modifications. Monolayers were washed with solution A
and treated with 25 µg/ml trypsin (crystallized three
times, Worthington Biochemical Corp ., Freehold, N . J .),
for 10 min at 37°C . At this time, all the cells had de-
tached from the plate and an equal volume of soybean
trypsin inhibitor solution (Worthington, 50 µg/ml) was
added. The cell suspension was centrifuged, washed, and
resuspended in solution A . After preincubation, cellswere incubated with antiserum as above . After 10 min,
incubation mixtures were diluted twofold and cells were
centrifuged, washed, and counted . Controls with no cells
or clones without antigenic reactivity in the hemolysis
assay were at background level in the binding assay . The
binding is linear with antiserum concentration (61) .
RESULTS
Synchronization
4 h after release from the second thymidine
block, the cell number began to increase (Fig . I) .
Between 85 and 100% of the cells divided within
the next 4 h. 1-h pulses with radioactive thymidine
showed that incorporation of label into alcohol-
precipitable material was high after release from
thymidine block (Fig . 2 A). By 4 h after the release
when mitotic cells began to appear, the level of
incorporation into precipitable material was lower .
This low level was maintained for at least 5 h when
the experiment was terminated . These results
suggest that cells released from a double thymidine
block are in S phase but not at the G,-S border .
Instead, these cells exhibit shorter S and G 2 phases
than expected, as observed by Bostock et al . (59) .
Decreasing the length of excess thymidine block
from 10 to 8 h resulted in a slightly longer lag
before cell division (data not shown) . The results
obtained by exposing cells which were released
from a double thymidine block to ["C]palmitic
FIGURE I Cells were seeded onto 20-cm' petri dishes .
At the times indicated, the cell monolayer was washed
twice with serum-free medium, and fresh medium con-
taining thymidine or deoxycytidine was added . Control
cells were washed and fed with fresh medium at the same
time. The arrow indicates the beginning of the time-scale
for the synchronized population . Ti) = generation time .
o	 o, control cells . o---o, synchronized cells .
FIGURE 2 Cells on cover slips were pulsed for I h with
[methyl- 3H]thymidine, either 10 µCi/ml A, or I µCi/ml
B, washed in solution A, and methanol precipitated .
Cover slips were counted in a liquid scintillation count-
ing system . The bars indicate variation in duplicate
plates . (A) Cells were blocked twice with excess thymi-
dine as detailed in Materials and Methods . Zero time
represents release from the second block . (B) Mitotic
cells were collected by a 2-h exposure to Colcemid 5 h
after release from the second thymidine block . Zero time
represents release from Colcemid arrest .
acid are shown in the right third of Tables II and
III . The 0-4-h period probably represents cells in
all parts of S, while the 4-8-h period undoubtedly
contains a mixture of cells in all phases .
In an attempt to obtain cells synchronized in G,
and the beginning of S, cultures released from a
double thymidine block were mitotically collected
in Colcemid . Cultures released from the double
block did not yield enough mitotic cells for our
biochemical studies unless Colcemid was added to
prevent exit from mitosis . Colcemid collection for
2 h during the sharp cell-doubling period shown in
Fig. I yielded 10-40 million cells . Routinely > 95%
and often >98% mitotic cells were obtained . These
cells attached within 0 .5 h and were completely
flattened by I h . Pulses with [ 3H]thymidine (Fig . 2
B) suggested that S phase began at 4-6 h after
mitosis. However, cells were still in S phase 15 h
after mitosis . Until 16 h after mitosis, no mitotic
cells were observed. After 16 h cell number began
gradually to increase (data not shown) . The dou-
bling time of NIL 2C1 was 15-16 h (Fig . 1) .
Protein content increased gradually during the
mitotic cycle (Fig. 3). During the first 3 h after
collection, no more than 10% of the cells were in S
phase. In the next hour, 25% of the cells had
entered S. By 8 h after collection, 75% of the cells
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679FIGURE 3 Protein was determined on whole cells by the
method of Lowry et al . (57) . Bars indicate variation
between duplicate plates . (A) Mitotic cells were collected
by Colcemid arrest 5 h after release from the second
thymidine block . Zero time represents release from
Colcemid arrest . (B) Cells were blocked twice with excess
thymidine . Zero time represents release from thymidine
block .
TABLE I
Glycolipid Nomenclature*
Ceramide-glc
Ceramide-gal
Ceramide-glc-gal
Ceramide-glc-gal-gal
Ceramide-glc-gal-gal-gaINAc
Ceramide-glc-gal-gal-galNAc-gaINAc
Ceramide-gic-gal-NANA
Ceramide-glc-gal-NGNA
GL-1
GL-2
GL-3
GL-4
GL-5
GM,
*Abbreviations : glc, D-glucose ; gal, D-galactose ;
galNAc, N-acetyl-D-galactosamine ; NANA, N-acetyl-
neuraminic acid; NGNA, N-glycolyl-neuraminic acid .
were in S phase . By 10 h, all of the cells were
incorporating [ 3H]thymidine (Fig . 2, continuous
labeling data not shown) . Although no increase in
cell number was observed before 16 h, the gradual
cell doubling seen afterwards suggests a loss of
synchrony . The period between 12 and 16 h after
Colcemid release consists of cells in S and G 2
phases, but contains few M and G, cells because no
cell doubling or mitotic cells were seen .
Lipid Analysis
The structure and nomenclature of the glycolip-
ids studied are given in Table I . Unidentified spots
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FIGURE 4 Cells were labeled with I JCi/ml radioactive
palmitate for 4 h, washed, and scraped . Cells were
extracted with chloroform-methanol (2 :1) and run on
thin-layer chromatography as detailed in Materials and
Methods. The graph represents a summation of counts
per minute incorporated into all the phospholipids and
glycolipids divided by the number of cells extracted . Bars
represent variations observed between three separate
experiments . (A) Cells were mitotically harvested 5 h
after release from a double thymidine block . Zero time
represents release from Colcemid block . (B) Cells re-
leased from the double thymidine block . Zero time
represents the release from the second block .
were preliminarily characterized by incorporation
of [ 32P]phosphoric acid, [ 14C]palmitate, and
(d 4C]sugars but were not further examined .
Incorporation of palmitate into total phospho-
lipids and glycolipids increased on a per cell basis
as the cell progressed through the cycle (Fig . 4),
but considerable labeling occurred in G, (Fig . 4 A) .
The decrease in incorporation per cell seen in Fig .
4 B is due to the doubling in cell number by 8 h .
The percentage of counts in several phospholipid
spots in a 4-h pulse With palmitate, averaged over
three experiments, is shown in Table II . In the
chromatographic system used, sphingomyelin
(SM) and phosphatidylcholine (PC) did not sep-
arate w ell . SM + PC represented 75-80% of the
palmitate incorporation, phosphatidylethanol-
amine represented 8%, and phosphatidylinositol
was 5%. Longer labeling periods gave similar dis-
tributions (reference 13, and B . A. Wolf, unpub-
lished observations). Each phospholipid incor-
porated palmitate at the same rate during all
phases of the cell cycle .
In Table 111, the labeling pattern of the glycolip-
ids is shown . GL-1, GL-2, and G M , showed no
preferential labeling during any phase of the cell
cycle. On the other hand, GL-3 was labeled during
G, and GL-4 was labeled during G, and early S .
Fig. 5 A shows the variation among experiments in
the fraction of the radioactivity in GM , . There wasno significant variation in the degree of labeling
during any time period. Fig. 5 B shows the same
data for GL-4. Within a given experiment, the
incorporation into GL-4 was always greatest in G,
and early S, and decreased or was not observed in
late S and G2. GL-3 represented so few counts that
it was difficult to find in most autoradiograms .
One experiment done with mitotically collected
TABLE II
Incorporation of ["C] Palmitate into Phospholipids*
cells was exposed to X-ray films for 2 mo. In the
first two labeling periods, GL-3 was observed but
no radioactive spot could be found in the cells in
the last two periods even though comparable total
counts were spotted . Since background was
<0.01, GL-3 in the 8-12- and 12-16-h periods
must be <_0.01 . In contrast to the other lipids, the
pattern of labeling of GL-5 was quite variable and
Cells were labeled with l µCi/ml radioactive palmitate for 4 h and the lipids were isolated and analyzed by thin-layer
chromatography as detailed in Materials and Methods . On the left side is shown the average of three experiments
performed on cells released from a mitotic collection with Colcemid after a double thymidine block . On the right third
is shown the average of three experiments performed on cells released after a double thymidine block . The total counts
per minute varied between experiments from 6 .5 x 10` to 3.0 x 10° cpm/4-h period. Background was <0 .01% of
total.
* Numbers are expressed as incorporation into phospholipid divided by incorporation into phospholipids plus
glycolipids x 100. Numbers are averages of three separate experiments which differed by no more than 10% .
TABLE III
Incorporation of ["C]Palmitate into Glycolipids*
* Numbers are expressed as incorporation into glycolipid divided by incorporation into phospholipids plus glycolipids
x 100. Numbers are averaged over three separate experiments (except for GL-3) .
$ ±0.4.
§ ±0.02.
11 Detected in only one experiment .
¶ Variations between experiments were sometimes large but consistent within a given experiment . See Fig. 5 .
** ±0.2.
$$ See Fig. 5.
ND = not determined .
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Mitotic release Double T release
M - G, - S - G, - M S-G,-M
Labeling times 0-4 4-8 8-12 12-16 16-19 0-4 4-8
Spot
GL-1$ 1.70 1.50 1.20 1.30 0.94 1.70 1 .90
GL-2§ 0.03 0.04 0.03 0.03 0.03 0.04 0.02
GL-311 0.08 0.06 _<0.01 <0.01 ND ND ND
GL-41f 0.37 0.45 0.31 0.07 0.16 0.06 0.06
GL-5** 0.47 0.61 0.58 0.67 0.41 0.28 0.22
GM , $$ 1.05 1.20 1.18 1.15 1 .00 1.06 1 .20
See legend to Table II .
Mitotic release Double T release
- M S - G, - M M - G, - S
	
- G,
Labeling times 0-4 4-8 8-12 12-16 16-19 0-4 4-8
Spot
Sphingomyelin + Phosphatidylcho- 81 .8 78.8 75.3 77.9 76.6 79.1 76.0
line
Phosphatidylethanolamine 6.0 8.4 9.6 9.0 8.7 7.8 7.8
Phosphatidylinositol 3.4 3.5 4.8 3.7 5 .2 4.1 5.3no systematic pattern was observed either in
individual experiments or in the average of several
experiments .
In order to clarify the labeling pattern of GL-5
and to confirm the results with the other glycolip-
ids, synchronized cells were labeled with
["C]glucosamine . Several laboratories have found
that glucosamine is incorporated into acid-insolu-
ble material as N-acetylglucosamine, N-acetyl-
galactosamine, and N-acetyl- (or glycolyl)-
neuraminic acid (62-65) . In contrast to the palmi-
tate label, the total incorporation of glucosamine
into acid -precipitabie material was highest in G,
(see Fig. 6 A). Incorporation into the glycolipids
represented between I and 2% of the total at all
times (Fig. 6 B). The glycolipids probably were
labeled only in N-acetylgalactosamine or neura-
FIGURE 5 Cells were labeled with I uCi/ml radioactive
palmitate for 4 h and the lipids separated as detailed in
Materials and Methods . On the left of the graphs are
shown glycolipids isolated from cells released from
Colcemid collection after a double thymidine block . On
the right of the graphs are shown glycolipids isolated
from cells released from a second thymidine block . The
bars represent variations between three separate experi-
ments . (A) G M3 . (B) GL-4 .
TABLE IV
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minic acid (see Table I) since metabolism of label
to other lipids (GL-1, GL-2, and phospholipids)
was not observed, suggesting that radioactive
glucosamine did not enter the carbon pool . As
shown in Table IV, approximately equal incorpo-
ration of glucosamine into GM µ occurred during all
labeling periods, except for 8-12 h . Incorporation
into GL-4 was slightly higher in G, and early S
than in late S and G2 . GL-5 was clearly labeled at
all phases but incorporation decreased in late S
and G 2 .
The incorporation of radioactive galactose in
4-h periods during the mitotic cycle is shown in
Table V . It has been found that > 85% of the label
remains as radioactive galactose in acid-insoluble
material (64) . When radioactive galactose is me-
tabolized it is found as glucose and amino acids
FIGURE 6 Cells released from a Colcemid collection
after a double thymidine block were labeled for 4 h with
2.5 sCi/ml glucosamine-HCI . After washing with solu-
tion A, cells were scraped. Aliquots were precipitated
with 5% cold trichloroacetic acid, filtered, and counted,
(A) . The remainder was extracted with chloroform-
methanol (2 : I) and the lipids were separated as detailed
in Materials and Methods . The total counts per minute
incorporated into the glycolipids were graphed, (B) . The
bars represent variation in duplicates . Protein was deter-
mined on whole cells (A), or lipid-extracted cells, (B) .
Zero time was at release from Colcemid arrest .
Cells were mitotically harvested after release from double thymidine block, as detailed in Materials and Methods, and
labeled for 4 h with 2 .5 juCi/ml ["C]glucosamine-HCI . Zero time represents release from Colcemid arrest . Labeling
medium contained 1,000 x molar excess of glucose . Lipids were analyzed as described in Materials and Methods .
Protein was determined on lipid-extracted cells .
* Numbers are expressed as counts per minute incorporated into glycolipids per microgram protein .
I Numbers are the average of duplicates ° variation in duplicates .
§ 3 x background levels .
Incorporation of ['"C]Glucosamine into Glycolipids*
Labeling times 0-4 4-8 8-12 12-16
Spot
GL-4 0.52°0 .2t 0.62°0 .4 0.22°0 .07 0.17°0 .06§
GL-5 4.7°0 .4 5.3°0 .1 2.8°0 .1 2.1°0 .1
GM,, 0.48°0 .04 0.35°0 .07 0.16°0 .01 0.44°0 .08(64, 65). Although all the glycolipids were labeled
during the 4-h exposure to radioactive galactose,
no label was found in the phospholipids which
represent the majority of lipids in the cell . The lack
of conversion of galactose label is probably a result
of the excess of glucose (25 mM) and amino acids
0.3-3 mM) over galactose (0 .03 mM) in the
labeling medium . The amount of label incorpo-
rated into GL-l, GL-2, and GM;, varied no more
than twofold during all labeling periods. GL-3 was
labeled more heavily in G 1 and early S phases .
GL-4 was labeled more heavily in G 1 and S phases .
GL-5 incorporated galactose during the whole
mitotic cycle but incorporation decreased in S and
Gz phases. The glucosamine and galactose incor-
poration data are consistent with the palmitate
incorporation (see Fig . 7).
Immunology
Since one of these glycolipids has been identified
as the Forssman antigen (44), we were interested in
the immunological reactivity of this lipid . An assay
was devised based on the lysis of sheep red blood
cells by hemolysis. This assay is highly specific and
also highly sensitive, detecting picomoles of lipid
antigen (61). Only GL-5 inhibited hemolysis
(Table VI). Daily variations, perhaps due to the
state and batch of red blood cells, necessitated the
inclusion of both hemolysin and antigen standards .
In Table V II the total amount of antigen per cell
in lipid extracts averaged over four determinations
is shown . The amount of lipid antigen gradually
increased two- to threefold during the mitotic
TABLE V
Incorporation of [ 14C]Galactose into Glycolipids*
Cells were mitotically harvested after release from double thymidine block, as detailed in Materials and Methods, and
labeled for 4 h with 2 .5 §Ci/ml ["C]galactose. Zero time represents release from Colcemid arrest . Labeling me-
dium contained 1,000 x molar excess of glucose and 10-100 x molar excess of amino acids . Lipids were analyzed
as described in Materials and Methods . Protein was determined on lipid-extracted cells.
* Numbers are expressed as counts per minute incorporated into glycolipids per microgram protein .
$ Numbers are the average of duplicates µ variation in duplicates .
°3 x background.
FIGURE 7 Cells were synchronized by a double thymi-
dine block or by mitotic collection from monolayer after
a double thymidine block . Cells were labeled for 4 h with
l §Ci/ml palmitate, 2 .5 §Ci/ml galactose, or 2 .5 §Ci/ml
glucosamine-HCI, and lipids analyzed as described in
Materials and Methods. The cross-hatched bars repre-
sent incorporation of palmitate. The dotted bars repre-
sent incorporation of galactose . The filled bars represent
incorporation of glucosamine . The divisions of the mi-
totic cycle are approximate and are included to facilitate
comparison.
cycle. Because of the large variations, these results
should be interpreted cautiously but are consistent
with synthesis of GL-5 throughout the mitotic
cycle.
In Fig. 8, the binding of radioactive antiForss-
man antiserum to cells before and after trypsin
treatment is shown . The amount of antiserum
bound to trypsinized cells increased gradually until
8 h after mitosis . No additional binding was
observed when mitotic cells were trypsinized . As
the cells progressed through the mitotic cycle, the
proportion of antigen exposed by trypsin treatment
increased until 8 h after mitosis . Similar measure-
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Labeling times 0-4 4-8 8-12 12-16
Spot
GL-l 2.5 µ0.15 2.4 µ0.3 1 .5 µ0.3 2.9 µ0.3$
GL-2 0.40 µ 0.05 0.19 µ 0.05 0.24 µ 0.05 0.15 µ 0.04°
GL-3 1.8 µ0.3 0.92 µ0.2 0.62 µ0.3 0.41 µ0.15
GL-4 1.3 µ0.3 0.71 µ0.3 0.55 µ0.3 0.35 µ0.04
GL-5 10µ2 5 .7µI 6.2µ2 3.8µ0.05
GM, 9.3µ2 5 .4µ1 .5 8.0µ0.8 5.6µ1Lipids were extracted with chloroform-methanol (2 : I)
from 2.4 x 10' cells and separated on thin layer
chromatography, as detailed in Materials and Methods.
The lipids were eluted from the silica gel with 100%
methanol and rerun in one dimension in the first solvent .
Eluted lipids were diluted serially and assayed for ability
to inhibit hemolysis as detailed in Materials and
Methods.
TABLE VII
Total Forssman Antigen in Extracts of Cells during the
Cell Cycle
Cells were harvested from Colcemid after release from a
double thymidine block, as described in Materials and
Methods. Zero time represents release from Colcemid
arrest. Cells were harvested at the times indicated and
lipid was extracted. Samples were stored at -20°C until
assayed. Hemolysis was performed as detailed in Mate-
rials and Methods . 50% inhibition of hemolysis is
achieved with 5.7 pmol of GL-5 (61).
ments have shown that 60-70% of the antigen
detected in trypsinized growing cells and 70-95%
of antigen in trypsinized confluent cells is unavaila-
ble to antiserum before trypsin treatment (45, 61).
DISCUSSION
We have attempted to obtain populations of highly
synchronous cells . In order to study the glycolipids
which are present at very small levels (< 5%), large
numbers of cells were necessary. For this reason
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TABLE VI
Quantitation of GL-5 by the Hemolysin Assay
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FIGURE 8 Radiolabeled antiForssman antiserum (12 .5
µg, 1,000 cpm/µg) was added to untreated or trypsin-
treated (10 min, 25 µg/ml) monolayers of cells mitoti-
cally harvested in Colcemid after release from a double
thymidine block. Bars or linked X's indicate variation
between duplicates . Zero time is at release from Colce-
mid arrest. Background <0 .3%. g	g, trypsin
treated. *---~, untreated.
we first employed a double block of excess thymi-
dine (53) and modified the technique to our NIL
clone. Initial experiments showed that 2-3 mM
thymidine arrested cell division and was com-
pletely reversible, resulting in cell doubling by 10 h
after release (Fig. I and reference 61). Although
cultures synchronized by the double excess thymi-
dine procedure were enriched for S-phase cells,
shortening of the S + G 2 phases was observed and
the moderate degree of synchrony deteriorated by
8 h. In an effort to regain a synchronized culture,
Colcemid was added to arrest exit from mitosis .
The level of Colcemid used was also reversible as
long as exposure was brief . Prolonged treatment
with Colcemid led to loss of viability. However, by
a 2-h treatment with Colcemid, 10-40 million cells
with mitotic index of 95-99% were obtained . These
cells attached to the substratum within a half hour
and were completely flattened by I h after release .
No incorporation of radioactive thymidine was
observed until 4 h after release . By 8 h after
release, 75% of the cells were in S . No mitotic cells
were observed until after 16 h. In our hands, the
mitotic harvest from monolayer cultures resulted
in highly synchronous populations which were
viable and retained synchrony for most of the
generation time (15-16 h).
It is possible that the use of excess thymidine
Dilution- ' of
sample giving
50% inhibition
Glycolipid
	
of hemolysis
NIL 2CI cell extract 80,000
GL-5 46,000
G L-4 15
GL-3
	
< 8
GL-2
	
< 8
GL-1
	
<8
GMS
	
<8
Time after
mitotic collection Antigen
h pmol/cell
0 0.086 t 0.023
4 0 .11 t 0.005
8 0.13 t 0.051
11 0.13 t 0.062
14 0.21 t 0.023and Colcemid may have introduced perturbations
in macromolecular synthesis . It has been observed
in HeLa cells that the continued presence of
inhibitors of DNA synthesis, including thymidine,
resulted in unbalanced growth (66), that is, synthe-
sis of RNA and protein in the absence of DNA
synthesis . After 48 h, protein and RNA content
doubled, as did cell volume . However, Cohen and
Studzinski did not release cells from the inhibitors
to see whether cells remained viable during the
prolonged block . From observations with our
clone, we would expect that prolonged exposure to
inhibitors of DNA synthesis would significantly
reduce viability. Although such unbalanced growth
may occur during the double block procedure of
the NIL clone, we tried to minimize perturbations
by blocking for as short a time as possible and by
using a low concentration of thymidine. The
viability of the NIL cells subjected to a double
thymidine block remained high, as evidenced by
the high yield of cell doubling, 85--100% . The
concentration of thymidine used resulted in an
incomplete block to DNA synthesis, as evidenced
by the shortened S + G 2 phase, probably due to
slow movement of cells through S phase (59).
Cohen and Studzinski did not observe that the
unbalanced growth in the absence of DNA synthe-
sis was harmful to the cell. We also do not have
any evidence to suggest any harmful effects during
the short exposure to thymidine. On the contrary,
the cells released from a double thymidine block
were highly viable, were able to divide, and, in the
generation time after Colcemid collection, doubled
their protein content (see Fig . 3 A). Although the
use of inhibitors may have resulted in unbalanced
growth during blockage of DNA synthesis, we
have observed nothing to suggest that the cells
were adversely effected . In addition, our results
with total lipid synthesis agree with Pasternak and
colleagues (21, 23, 24), who did not use inhibitors .
In agreement with Pasternak and colleagues (21,
23, 24), who studied a mouse mastoma, radioactiv-
ity was incorporated into the majority of lipids
during all phases of the NIL cell cycle . This was
true both for total lipids and for the majority of
specific lipids. In contrast, Bosmann and Winston
(26-28) have found synthesis of membrane compo-
nents in S phase although glycolipids were made
only in G2. However, the lymphoma line studied by
Bosmann has a short doubling time with almost no
G, and G2.
On the other hand, using similar labels, Gerner
and collaborators observed incorporation during
G, in human KB cells (20), while Nowakowski et
al. reported a peak of fucose incorporation in G2
(22). Plasma membranes were isolated by Gerner
et al. and Nowakowski et al., but no attempt was
made in any of these studies to fractionate the
labeled components (protein or lipid) . The differ-
ent results could be due to variations in cell lipid
composition, differences between plasma mem-
branes and whole cells, different methods and
degrees of synchrony, or variations in the synthesis
of membranes among cell types .
Our studies on the fibroblast line, NIL 2C1,
cannot resolve all these conflicts, but may suggest
reasons for the variations . Using highly synchro-
nous populations, we have confirmed the observa-
tion that most of the lipids are labeled throughout
the cell cycle. In addition, it is possible that a
special class of components can be made only
during a restricted part of the cycle. This special
class could differ for each cell line or for different
membrane fractions, i .e., plasma membrane vs .
internal membrane.
The observation that the complex glycolipids are
made during G, and early S shows an interesting
parallel with studies performed during the growth
cycle (4, 12-16). GL-3 was not significantly labeled
until cells became confluent . GL-4 was labeled
somewhat at low densities but incorporation in-
creased at confluence . GL-5 was labeled at all
densities but the highest rate of incorporation was
in confluent cells. GL-3 and GL-4 were also
labeled preferentially during G, and early S, while
GL-5 was labeled during all phases of the cycle
(although at a higher rate in G,). Thus, the
incorporation of label into GL-3 and GL-4 is
restricted during the cell cycle and in growing
cultures while the incorporation of label into GL-5
is less restricted .
We have used the term "rate of labeling" instead
of "synthetic rate" because we cannot exclude the
possibility of turnover . It was assumed that rapidly
growing cells might be synthesizing membrane
components at a maximal rate and that degrada-
tion would be minimal . By using radioactively
labeled fatty acid and sugars, the possibility of
inaccurate synthetic rates due to turnover was
reduced. Degradation of the whole molecule, how-
ever, cannot be ruled out . The equal rate of
labeling of some of the glycolipids throughout the
cycle makes the possibility of artifacts due to pool
sizes unlikely. We found no differences in the
BARBARA ANNE WOLF AND P . W. ROBBINS Mitotic Cycle Synthesis of Glycolipids 685neutral lipid fraction (which includes precursor
pools) during the mitotic cycle .
The state of the cell surface during the cell cycle
is another intriguing problem . As stated above,
many different antigenic sites are "exposed" dur-
ing mitosis (30-37) . Although this may be a
consequence of release of substances attached to
the surface, e.g., heparan sulfate or other glyco-
sylaminoglycans, some rearrangement of the
existing architecture may also be involved . The
mitotic cell seems to resemble a trypsinized cell,
for example, in the spherical rounding of a
flattened cell and in the more tenuous attach-
ment to the substratum.
Alternatively, trypsin treatment or mitosis may
result in greater mobility of membrane compo-
nents. A third hypothesis is that mitosis and G are
the times in the cell cycle when antigenic sites are
inserted into the membrane . Subsequently, they
either become diluted in the bilayer as more
phospholipid backbone is assembled, or covered by
other membrane proteins or by extracellular mate-
rial . In this context, it is interesting that Sander
and Pardee (19) found decreased transport rates in
mitosis and early G, which quickly returned to
interphase-specific activity (rate per milligram
protein) by late G, and S . We are currently
investigating the release of extracellular material
and the insertion of new material which is exposed
to the surface . A fourth hypothesis is that mitotic
cells are resistant to trypsin exposure of antigen .
However, both the labeling data and immunologi-
cal quantitation of GL-5 tend to exclude this
possibility.
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Addendum
After this manuscript was submitted, Chatterjee et al .
published a paper on the synthesis of glycolipids in
synchronized KB cells (Chatterjee, S ., C . C. Sweeley,
and L . F. Velicier. 1973. Biochem. Biophys. Res. Com-
mun. 54:585). They observed a peak of incorporation of
radioactively labeled galactose into acid-insoluble mate-
rial during S and a peak of galactose incorporation into
18
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gangliosides and neutral glycolipids during G2. However,
they did not separate any of the labeled components,
hence comparison with our results is difficult .
Received for publication 27 August 1973, and in revised
form 29 January 1974.
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